Wang, Yanrong http://orcid.org/0000-0001-6403-913X
He, Yuanyuan
Li, Weihong
LI, Hongmin
Tang, Liyuan
Dai, Xinya
Pei, Yingzi
Gao, Lijing
Clinical trials referenced in this document:
Documents that mention this clinical trial
Evaluation of Ornidazole Tablets Bioequivalence in Chinese Healthy Participants Under Fasted and Fed Conditions Using Pharmacokinetic Parameters
https://doi.org/10.1007/s40268-024-00457-7
Article History
Accepted: 12 February 2024
First Online: 22 April 2024
Declarations
:
: Zhejiang Aisheng Pharmaceutical Co. Ltd, and Beijing Fuyuan Pharmaceutical Co. Ltd.
: Lijing Gao and Yingzi Pei are affiliated with Beijing Fuyuan Pharmaceutical Co., Ltd. The authors disclose no further conflicts of interest in this study. Zhejiang Aisheng Pharmaceutical Co., Ltd. is a subsidiary of Beijing Fuyuan Pharmaceutical Co. Ltd. This article was related to the 2020 Hebei Province medical science research project (no. 20200340).
: This study was approved by the ethics committee of the Cangzhou Central Hospital (approval number 2021-061-01).
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Y.R.W. was principal investigator and contributed to all aspects of this study. Y.Y.H. and W.H.L. participated in conducting the study as a sub-investigator. Y.Z.P. and L.J.G. participated as an investigator and wrote the manuscript. L.Y.T. participated as a study assistant and contributed to manuscript drafting. X.Y.D., W.H.L., H.M.L., and L.Y.T. conducted the study as study assistants. H.M.L. contributed to study design and pharmacokinetic analysis.